Swedish Orphan Biovitrum AB (publ) (SOBI) - Total Liabilities

Latest as of March 2026: Skr40.87 Billion SEK ≈ $4.40 Billion USD

Based on the latest financial reports, Swedish Orphan Biovitrum AB (publ) (SOBI) has total liabilities worth Skr40.87 Billion SEK (≈ $4.40 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Swedish Orphan Biovitrum AB (publ) - Total Liabilities Trend (2002–2025)

This chart illustrates how Swedish Orphan Biovitrum AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See Swedish Orphan Biovitrum AB (publ) working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Swedish Orphan Biovitrum AB (publ) Competitors by Total Liabilities

The table below lists competitors of Swedish Orphan Biovitrum AB (publ) ranked by their total liabilities.

Company	Country	Total Liabilities
Joint Stock Company Kaspi.kz NASDAQ:KSPI	USA	$8.47 Trillion
Jiangxi Ganfeng Lithium Co Ltd SHE:002460	China	CN¥63.46 Billion
Atlassian Corp Plc NASDAQ:TEAM	USA	$4.77 Billion
Sprott Physical Gold Trust TO:PHYS	Canada	CA$3.42 Million
Evergreen Marine Corp Taiwan Ltd TW:2603	Taiwan	NT$284.91 Billion
JIO Financial Services Ltd NSE:JIOFIN	India	Rs177.13 Billion
PTC Inc NASDAQ:PTC	USA	$2.68 Billion
Banco de Sabadell S.A MC:SAB	Spain	€234.88 Billion

Liability Composition Analysis (2002–2025)

This chart breaks down Swedish Orphan Biovitrum AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Swedish Orphan Biovitrum AB (publ).

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.50	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Swedish Orphan Biovitrum AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Swedish Orphan Biovitrum AB (publ) (2002–2025)

The table below shows the annual total liabilities of Swedish Orphan Biovitrum AB (publ) from 2002 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr29.71 Billion ≈ $3.20 Billion	-15.47%
2024-12-31	Skr35.15 Billion ≈ $3.78 Billion	-12.48%
2023-12-31	Skr40.16 Billion ≈ $4.32 Billion	+54.63%
2022-12-31	Skr25.97 Billion ≈ $2.79 Billion	+2.02%
2021-12-31	Skr25.46 Billion ≈ $2.74 Billion	-9.33%
2020-12-31	Skr28.08 Billion ≈ $3.02 Billion	-2.27%
2019-12-31	Skr28.73 Billion ≈ $3.09 Billion	+252.79%
2018-12-31	Skr8.14 Billion ≈ $876.32 Million	+93.77%
2017-12-31	Skr4.20 Billion ≈ $452.24 Million	-9.04%
2016-12-31	Skr4.62 Billion ≈ $497.17 Million	+27.57%
2015-12-31	Skr3.62 Billion ≈ $389.72 Million	+95.98%
2014-12-31	Skr1.85 Billion ≈ $198.86 Million	+5.59%
2013-12-31	Skr1.75 Billion ≈ $188.34 Million	+18.21%
2012-12-31	Skr1.48 Billion ≈ $159.32 Million	-14.73%
2011-12-31	Skr1.74 Billion ≈ $186.83 Million	-36.34%
2010-12-31	Skr2.73 Billion ≈ $293.49 Million	+87.73%
2009-12-31	Skr1.45 Billion ≈ $156.34 Million	+12.28%
2008-12-31	Skr1.29 Billion ≈ $139.24 Million	+161.12%
2007-12-31	Skr495.50 Million ≈ $53.32 Million	-28.79%
2006-12-31	Skr695.87 Million ≈ $74.89 Million	-31.81%
2005-12-31	Skr1.02 Billion ≈ $109.82 Million	+196.35%
2004-12-31	Skr344.34 Million ≈ $37.06 Million	+23.90%
2003-12-31	Skr277.92 Million ≈ $29.91 Million	+4.25%
2002-12-31	Skr266.58 Million ≈ $28.69 Million	--

About Swedish Orphan Biovitrum AB (publ)

ST:SOBI Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$16.19 Billion

Skr150.44 Billion SEK

Market Cap Rank

#1532 Global

#22 in Sweden

Share Price

Skr435.00

Change (1 day)

+0.00%

52-Week Range

Skr264.40 - Skr447.20

All Time High

Skr447.20